| Financial Year |
March 31 2023 |
| Monetary Funds |
1,780,291,834.79 |
| Held-for-trading Financial Assets |
343,070,108.46 |
| Notes Receivable |
55,237,337.05 |
| Accounts Receivable |
2,138,271,327.13 |
| Advances to Suppliers |
66,908,836.96 |
| Other Receivables |
44,776,021.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,001,686,196.47 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
164,066,010.46 |
| Total Current Assets |
7,041,640,784.31 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
43,102,275.06 |
| Investment Properties |
105,533,184.11 |
| Fixed Assetes |
1,853,682,342.11 |
| Under-construction Projects |
249,787,553.89 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
594,272,066.20 |
| R&D expenses |
83,838,006.34 |
| Goodwill |
110,732,042.84 |
| Long-Term Deferred and Prepaid Expenses |
139,496,951.41 |
| Deferred Income Tax Assets |
138,897,783.46 |
| Other Non-Current Assets |
230,691,907.80 |
| Sub-Total of Non-Current Assets |
3,656,994,957.25 |
| Total Assets |
10,698,635,741.56 |
| Short-Term Loans |
510,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
948,777,881.00 |
| Accounts Payable |
1,652,607,969.14 |
| Accounts Received In Advance |
2,268,843.39 |
| Employee Compensation Payable |
103,158,765.61 |
| Taxes Payable |
69,646,113.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
294,084,875.96 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
85,149,447.33 |
| Other Current Liabilities |
23,433,819.86 |
| Sub-Total of Current Liabilities |
3,857,565,665.30 |
| Long-term Loans |
753,120,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
59,989,109.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
899,477,611.35 |
| Total Liabilities |
4,757,043,276.65 |
| Paid-In Capital(Or Share Stock) |
1,269,535,372.00 |
| Capital Surplus |
2,284,880,675.51 |
| Surplus Reserve |
214,764,194.14 |
| LESS:Treasury Stock |
284,257,854.91 |
| Undistributed Profits |
2,367,879,398.62 |
| Minority Stockholder's Interest |
92,857,834.87 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,848,734,630.04 |
| Owner's Equity（Stockholder's Equity） |
5,941,592,464.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,698,635,741.56 |
